Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Apr 25;56(7):1259-1267.
doi: 10.1007/s43465-022-00635-2. eCollection 2022 Jul.

Aggressive Presentation and Rapid Progression of Osteonecrosis of the Femoral Head After COVID-19

Affiliations

Aggressive Presentation and Rapid Progression of Osteonecrosis of the Femoral Head After COVID-19

Palanisami Dhanasekararaja et al. Indian J Orthop. .

Abstract

Background: We aim to report the consecutive patients diagnosed with osteonecrosis of femoral head (ONFH) following recovery from COVID-19 disease and elucidate the unique features of ONFH associated with COVID-19.

Methods: Consecutive 22 patients (39 hips) recovered from COVID-19 and presented with ONFH from November 2020 to October 2021 were included. All the patients received corticosteroids as a supportive treatment during COVID-19. Patients were classified into two types based on the type of presentation, namely classic ONFH and rapidly destructive coxarthrosis (RDC) depending on radiographs, MRI, inflammatory markers and hip aspiration findings. Harris hip score was used to evaluate the functional outcome before and after treatment.

Results: The mean time to diagnose of ONFH from the onset of hip symptoms was 39.3 days (range 10-90 days). The average duration of onset of hip symptoms after COVID 19 infection was 7.5 months (range 3 - 11 months). The average cumulative dose of methylprednisolone equivalent was 811 mg (range 200-2100 mg) and the average duration of steroid intake was 2.8 weeks. There was significant elevation in the inflammatory markers in RDC group compared to classic ONFH (p < 0.05). The Harris hip score improved from 63.6 ± 23.2 at presentation to 82.6 ± 9.6 after treatment (p < 0.05). Three patients had features of RDC. Among the three patients with RDC, two patients had rapid progression of ONFH and underwent total hip arthroplasty (THA). The third patient is awaiting a THA.

Conclusion: ONFH after COVID-19 can have a varied presentation. While the most common presentation is like classical ONFH, some patients can have an acute and aggressive presentation with rapid destruction. They have features like elevated serological markers and extensive periarticular bone and soft tissue edema. A low cumulative dose of steroids in our patients suggests that the COVID-19-associated vasculitis may play a role in the pathogenesis of ONFH.

Keywords: Avascular necrosis; COVID-19; Coronavirus; Femoral head; Musculoskeletal manifestation; Osteonecrosis of the femoral head (ONFH); Total hip arthroplasty.

PubMed Disclaimer

Conflict of interest statement

Conflict of InterestPalanisami Dhanasekararaja, Dhanasekaran Soundarrajan, kanugula Sandeep Kumar, BT Pushpa, Natesan Rajkumar and Shanmuganathan Rajasekaran declare that they have no conflict of interest.

Figures

Fig. 1
Fig. 1
MRI showing the bilateral osteonecrosis of femoral head with mild edema and necrotic angle calculation in midcoronal and midsagittal image. By modified kerboul method, the combined necrotic angle is measured and divided into four grades
Fig. 2
Fig. 2
a Radiograph showing subchondral cyst and osteolysis in the left femoral head. b MRI showing severe marrow and periarticular soft-tissue edema with joint effusion. c rapid progression and varus collapse of the femoral head at 2 months suggestive of rapid progressive coxarthrosis. d radiograph showing hybrid total hip arthroplasty. The intraoperative culture showed no growth

References

    1. Zhang S, Wang C, Shi L, Xue Q. Beware of steroid-induced avascular necrosis of the femoral head in the treatment of COVID-19—Experience and lessons from the SARS epidemic. DDDT. 2021;15:983–995. doi: 10.2147/DDDT.S298691. - DOI - PMC - PubMed
    1. https://covid19.who.int.
    1. Zhang B, Zhang S. Corticosteroid-induced osteonecrosis in COVID-19: A call for caution. Journal of Bone and Mineral Research. 2020;35(9):1828–1829. doi: 10.1002/jbmr.4136. - DOI - PMC - PubMed
    1. Guo KJ, Zhao FC, Guo Y, Li FL, Zhu L, Zheng W. The influence of age, gender and treatment with steroids on the incidence of osteonecrosis of the femoral head during the management of severe acute respiratory syndrome: A retrospective study. The Bone & Joint Journal. 2014;96-B(2):259–262. doi: 10.1302/0301-620X.96B2.31935. - DOI - PubMed
    1. Zhao R, Wang H, Wang X, Feng F. Steroid therapy and the risk of osteonecrosis in SARS patients: A dose-response meta-analysis. Osteoporosis International. 2017;28(3):1027–1034. doi: 10.1007/s00198-016-3824-z. - DOI - PMC - PubMed

LinkOut - more resources